Status:
COMPLETED
Assessing the Quality of Life and Social Support in Age-Related Macular Degeneration Patients
Lead Sponsor:
Asfendiyarov Kazakh National Medical University
Conditions:
Age-Related Macular Degeneration
Eligibility:
All Genders
30-90 years
Brief Summary
The aim of this study is to evaluate the quality of life of AMD patients related to vision using the short version of the National Eye Institute Visual Function Questionnaire (NEI-VFQ-25), patients' s...
Detailed Description
Background and study aims. Age-related macular degeneration (AMD) is the most prevalent chronic progressive ocular disease. It has been shown in several studies that AMD affects the quality of life of...
Eligibility Criteria
Inclusion
- age-related macular degeneration; ability to speak and understand Russian and/or Kazakh language; willingness to participate
Exclusion
- Presence of glaucoma, cataracts of grade 2 or more according to the Lens Opacities Classification System (LOCS) III, and the presence of corneal opacities or any other retinal diseases
Key Trial Info
Start Date :
April 5 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 27 2022
Estimated Enrollment :
458 Patients enrolled
Trial Details
Trial ID
NCT05427994
Start Date
April 5 2021
End Date
July 27 2022
Last Update
September 1 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Kazakh Scientific - Research Institute of Eye Diseases
Almaty, Kazakhstan, 050012
2
Medical Centre Hospital of President'S Affairs Administration of the Republic of Kazakhstan
Astana, Kazakhstan, 010000